Calcium channel blockers potentiate gemcitabine chemotherapy  in pancreatic cancer

There is currently no effective treatment for pancreatic ductal adenocarcinoma (PDAC). While palliative chemotherapy offers a survival benefit to most patients, nearly all will eventually progress on treatment and long-term survivability remains poor. Given the lack of subsequent line treatment opti...

Descripción completa

Detalles Bibliográficos
Autores principales: Principe, Daniel R., Aissa, Alexandre F., Kumar, Sandeep, Pham, Thao N. D., Underwood, Patrick W., Nair, Rakesh, Ke, Rong, Rana, Basabi, Trevino, Jose G., Munshi, Hidayatullah G., Benevolenskaya, Elizaveta V., Rana, Ajay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Academy of Sciences 2022
Materias:
Biological Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9170157/
https://www.ncbi.nlm.nih.gov/pubmed/35476525
http://dx.doi.org/10.1073/pnas.2200143119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9170157/
https://www.ncbi.nlm.nih.gov/pubmed/35476525
http://dx.doi.org/10.1073/pnas.2200143119

Ejemplares similares